376 related articles for article (PubMed ID: 16024603)
21. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
Wang Q; Sun Z; Yang HS
Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
[TBL] [Abstract][Full Text] [Related]
23. siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression.
Bitomsky N; Wethkamp N; Marikkannu R; Klempnauer KH
Oncogene; 2008 Aug; 27(35):4820-9. PubMed ID: 18427550
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.
Roop DR; Krieg TM; Mehrel T; Cheng CK; Yuspa SH
Cancer Res; 1988 Jun; 48(11):3245-52. PubMed ID: 2452688
[TBL] [Abstract][Full Text] [Related]
25. Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK
Cancer Res; 2000 Feb; 60(3):595-602. PubMed ID: 10676642
[TBL] [Abstract][Full Text] [Related]
26. Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors.
Kalinichenko SV; Kopantzev EP; Korobko EV; Palgova IV; Zavalishina LE; Bateva MV; Petrov AN; Frank GA; Sverdlov ED; Korobko IV
Lung Cancer; 2008 Nov; 62(2):173-80. PubMed ID: 18457901
[TBL] [Abstract][Full Text] [Related]
27. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
Wang XJ; Greenhalgh DA; Roop DR
Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
[TBL] [Abstract][Full Text] [Related]
28. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas.
Williams IR; Ort RJ; Daley D; Manning L; Karaoli T; Barnhill RL; Kupper TS
J Immunol; 1996 May; 156(9):3382-8. PubMed ID: 8617964
[TBL] [Abstract][Full Text] [Related]
29. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
[TBL] [Abstract][Full Text] [Related]
30. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
31. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
[TBL] [Abstract][Full Text] [Related]
32. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
[TBL] [Abstract][Full Text] [Related]
33. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G
Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090
[TBL] [Abstract][Full Text] [Related]
34. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.
Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA
Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724
[TBL] [Abstract][Full Text] [Related]
35. Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.
Kato Y; Tsukuda M; Nagashima Y; Koshika S; Sakai N; Yao M; Kubota Y; Aoki I; Colledge WH; Foidart JM; Hata R; Thompson EW
Int J Oncol; 2005 Sep; 27(3):759-68. PubMed ID: 16077926
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of CCAAT/enhancer binding protein family DNA binding in mouse epidermis prevents and regresses papillomas.
Oh WJ; Rishi V; Orosz A; Gerdes MJ; Vinson C
Cancer Res; 2007 Feb; 67(4):1867-76. PubMed ID: 17308129
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI.
Zakowicz H; Yang HS; Stark C; Wlodawer A; Laronde-Leblanc N; Colburn NH
RNA; 2005 Mar; 11(3):261-74. PubMed ID: 15661843
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.
Wheeler DL; Ness KJ; Oberley TD; Verma AK
Cancer Res; 2003 Jun; 63(12):3037-42. PubMed ID: 12810623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
